Cynapsus Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended 2015 Mar 9, 2022
Cynapsus Therapeutics Provides Company Update at Cowen & Co. 36th Annual Health Care Conference Mar 7, 2022
Cynapsus Therapeutics to Present at Noble Financial Capital Markets' Twelfth Annual Investor Conference Jan 13, 2022
Cynapsus and Michael J. Fox Foundation Collaborate on Pilot Use of Wearable Device and Data Science Approaches in Phase 3 Parkinson’s Clinical Study Jan 7, 2022
